Milestones

A Prelude

Cadila Pharmaceuticals (CPL) Ahmedabad, India, exemplifies a spirited Indian Enterprise. Its phenomenal growth is a corporate epic, an epoch in time nurtured by fifty-two years of rich, caring heritage. With a trail of creditable milestones, CPL today has evolved to become the undisputed leader in the Indian Pharmaceutical sector, with the largest therapeutic groups, it's operations spanning 45 countries. CPL is multi-locational, with it's global offices and infrastructure.

Milestones

Today, Cadila is proud of its achievements —

  • State-of-the-art formulations manufacturing facility, built to the exacting specifications of USFDA, TGA, MCA & MCC.
  • One of the best R & D set-ups in the country, manned by a 150-strong scientists' pool.
  • Strong Formulations Development base.
  • A host of 'Biotech' products launched, including many 'Firsts in India'.
  • World's First manufacturer of Immuvac- a unique Immunomodulator.
  • USFDA approvals for Fluoxetine & Ethambutol manufacturing facilities.
  • ISO 9002 approved Bulk Actives (APIs) manufacturing facility, offering facilities for contract research.
  • Asia's only manufacturer of 'SULFOLANE' (Tetramethylene Sulfone).
  • Significant global presence.
  • Leadership in Domestic Marketing and Distribution Management.
  • Leader in Indian Generics Market.

 

Diversifications

  • Hospital Disposables including Fiberglass Casting Tape for the first time in India
  • Diagnostics
  • Laboratory Chemicals
  • Pharmaceutical Machinery Manufacturing
  • Animal Health Formulations & Feed Supplements
  • Agro Business : Plant Tissue Culture and Bio-fertilizers.
  • Travel Business
  • Strategic Business Alliances with world-leaders

Today, Cadila Pharmaceuticals is all set to create new records, scale greater heights. It has created new world-class production and R&D facilities, focusing on research, new process innovations leading to patents, and meeting global standards. The Company always places the common man at its core – who should be able to access and afford our medicines anywhere in the world. For us at Cadila, this is the only true benchmark of excellence, and the only thing that really matters.